The controversy behind PrEP: Part 3 of our four-part series

Is PrEP’s promise too good to be true?
In the third part of our series on pre-exposure prophylaxis (PrEP), Daily Xtra looks at the controversy surrounding the HIV prevention drug. While many people are heralding a new chapter in the fight against HIV, others say it’s much too early to claim victory.